Gadi Peleg, Director at Artemis Therapeutics, Inc. (ATMS), sold 182 shares at $0.26 ($47) on 2018-12-18, disclosed to the SEC on 2018-12-19.
Open-market sale of $47 ATMS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.